cagrilintide with retatrutide vs CagriSema: The Battle Nobody's Covering Cagrilintide, Tirzepatide, and Retatrutide Peptides:
Description
This is because after this period, the bacteriostatic preservative can no longer prevent contamination, often leading to a compromised product that can put the patients at risk

Additional studies were obtained from references of identified studies, the Cochrane Library and the ISI Web of Knowledge

The FDA specifically warned about peptide-related impurities and API characterization problems in other words, that whats in the vial might not be 100% pure BPC-157, and even if it is, the peptide could degrade or contain variants

Critics have raised legitimate concerns

Richardson agrees

These may include pain, redness or swelling at the injection site, mild diarrhea, nausea, or itching of the skin
